IRONWOOD PHARMACEUTICALS INC
IRWDNASDAQ🏆 #2173 by market capUS Equity
$4.30▲ $0.28 (+6.44%)
Market closed · at close1h—
24h▲ 6.4%
7d▲ 4.1%
14d▲ 21.0%
30d▲ 2.0%
1y▲ 341.3%
🏦Market Cap
$708M
Small Cap
📈Revenue Growth (YoY)
+13.8%
Healthy
📊Gross Margin
100.0%
High
💵FCF Margin
35.2%
Strong
⚖️P/S Ratio
1.9x
Cheap
Otter Score
56
Weak
Trading Snapshot
- Day Range
- $4.28 – $4.32
- 52-Week Range
- $0.81 – $5.78
- Volume
- $5.89B
- Avg Volume
- $6.04B
- Shares Outstanding
- 164.6M
- Next Earnings
- Oct 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $366M
- Last Q Revenue
- $94M
- P/E Ratio
- 6.9
- P/S Ratio
- 1.9x
- EPS (TTM)
- $0.58
- Dividend Yield
- —
Why Investors Own IRWD
- ✓High-growth profile — revenue up +36.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 75% gross margin and 14% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$366M▲ +40.1% YoY
Gross Margin (TTM)
75.3%▲ +2.5% YoY
Operating Income (TTM)
$87M▲ +40.1% YoY
Free Cash Flow (TTM)
$51M▲ +40.1% YoY
About IRONWOOD PHARMACEUTICALS INC
A company profile for IRONWOOD PHARMACEUTICALS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
56/100
Analyst Price Target
ⓘAverage Target
$5.34
▲ +24.3% Upside
High Target$6.62
Low Target$4.46
Based on 12 analysts
Latest News & Updates
🚀
CNBC·2h ago
IRONWOOD PHARMACEUTICALS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift IRWD price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
IRONWOOD PHARMACEUTICALS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.